- Home
- SCLX vs EBMT Comparison
SCLX vs EBMT Comparison
Compare SCLX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCLX | EBMT |
|---|---|---|
| Founded | 2011 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.3M | 132.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SCLX | EBMT |
|---|---|---|
| Price | $14.09 | $19.75 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.9K | 43.2K |
| Earning Date | 11-14-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 58.15 |
| EPS | N/A | ★ 1.72 |
| Revenue | $40,360,000.00 | ★ $87,531,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $749.70 | $6.26 |
| P/E Ratio | ★ N/A | $11.50 |
| Revenue Growth | N/A | ★ 9.36 |
| 52 Week Low | $3.60 | $14.35 |
| 52 Week High | $34.27 | $20.22 |
Technical Indicators
Market Signals| Indicator | SCLX | EBMT |
|---|---|---|
| Relative Strength Index (RSI) | 36.11 | 77.58 |
| Support Level | $12.87 | $19.52 |
| Resistance Level | $20.62 | $20.22 |
| Average True Range (ATR) | 1.04 | 0.42 |
| MACD | -0.37 | 0.07 |
| Stochastic Oscillator | 18.54 | 82.54 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.